Metropolitan Life Insurance Company (MetLife)’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,038
| Closed | -$47.8K | – | 2278 |
|
|
2024
Q1 | $47.8K | Hold |
3,038
| – | – | ﹤0.01% | 1425 |
|
|
2023
Q4 | $49K | Hold |
3,038
| – | – | ﹤0.01% | 1459 |
|
|
2023
Q3 | $38.6K | Buy |
3,038
+289
| +11% | +$3.99K | ﹤0.01% | 1546 |
|
|
2023
Q2 | $38.7K | Hold |
2,749
| – | – | ﹤0.01% | 1581 |
|
|
2023
Q1 | $42.5K | Hold |
2,749
| – | – | ﹤0.01% | 1483 |
|
|
2022
Q4 | $45.1K | Hold |
2,749
| – | – | ﹤0.01% | 1540 |
|
|
2022
Q3 | $50.9K | Hold |
2,749
| – | – | ﹤0.01% | 1454 |
|
|
2022
Q2 | $36.1K | Hold |
2,749
| – | – | ﹤0.01% | 1702 |
|
|
2022
Q1 | $25.5K | Sell |
2,749
-8,274
| -75% | -$70.4K | ﹤0.01% | 1977 |
|
|
2021
Q4 | $108K | Buy |
11,023
+125
| +1% | +$2.35K | ﹤0.01% | 2435 |
|
|
2021
Q3 | $370K | Hold |
10,898
| – | – | 0.01% | 1647 |
|
|
2021
Q2 | $399K | Buy |
10,898
+540
| +5% | +$20.9K | 0.01% | 1670 |
|
|
2021
Q1 | $464K | Sell |
10,358
-315
| -3% | -$14.7K | 0.01% | 1471 |
|
|
2020
Q4 | $609K | Sell |
10,673
-789
| -7% | -$46.8K | 0.01% | 1235 |
|
|
2020
Q3 | $588K | Hold |
11,462
| – | – | 0.01% | 1101 |
|
|
2020
Q2 | $685K | Buy |
11,462
+5,034
| +78% | +$269K | 0.01% | 993 |
|
|
2020
Q1 | $265K | Buy |
6,428
+238
| +4% | +$13.2K | 0.01% | 1421 |
|
|
2019
Q4 | $385K | Buy |
6,190
+470
| +8% | +$22.3K | 0.01% | 1490 |
|
|
2019
Q3 | $194K | Buy |
5,720
+4,527
| +379% | +$134K | ﹤0.01% | 1893 |
|
|
2019
Q2 | $26.9K | Buy |
+1,193
| New | +$27.9K | ﹤0.01% | 2571 |
|
|
2018
Q4 | – | Sell |
-2,766
| Closed | -$107K | – | 2579 |
|
|
2018
Q3 | $107K | Buy |
+2,766
| New | +$102K | ﹤0.01% | 2412 |
|
Other funds holding DCPH
Metropolitan Life Insurance Company (MetLife)'s DCPH Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 3,038 shares — an estimated $47.8K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in DCPH in Q3 2018 and held it in 21 quarters. The position peaked at $685K in Q2 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 3,038 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $47.8K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 21 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $685K in Q2 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.